Damjan Osredkar
doctorMale0.0Global Dominance: 0.00%
Damjan Osredkar is the head of the Clinical Department of Pediatric, Adolescent, and Developmental Neurology at the Pediatric Clinic in Ljubljana, Slovenia. He is leading the GAIN-CTNNB1 clinical study, which aims to evaluate the safety and efficacy of the world's first gene therapy for CTNNB1 syndrome, marking a significant milestone in Slovenian medicine.
Power0
Reach0
Collect
Not in the pool (under ¢1).
Recent news mentions
Prof. Dr. Damjan Osredkar, head of the Clinical Department for Pediatric and Adolescent Neurology, stated the importance of timely treatment for Duchenne muscular dystrophy.
Inovativno zdravilo givinostat za otroke z DMDDelo – major Slovenian daily, est. 1959·
Slovenia· 2026-05-31
Slovenia· 2026-05-31Also mentioned
Sanja Kogelnik
Damjan Osredkar is the head of the clinical department for pediatric, adolescent, and developmental neurology at the pediatric clinic.
Deček Urban je prvi prejemnik genske terapije za sindrom CTNNB1Delo – major Slovenian daily, est. 1959·Slovenia· 2025-12-19
Slovenia· 2025-12-19
